The proposed multidisciplinary PhD of National Interest is aimed at investigating crucial aspects in the field of infections at epidemic-pandemic risk and offers advanced training in the following research fields:
- Innovative technologies for diagnosis: development of innovative diagnostic techniques for the timely and accurate identification of pathogens, such as viruses, bacteria, fungi and parasites, at epidemic-pandedmic risk.
- Vaccine Technologies: design and development of new vaccines, based on innovative technological platforms (e.g. mRNA), against pathogens at epidemic-pandemic risk
- Technologies for new antimicrobial drugs: research and development of new antimicrobial drugs, including antibiotics, antivirals, antifungals and antiparasitics, for infections at epidemic-pandemic risk.
- Monoclonal antibodies: design and development of antibodies, as an alternative or complement to antimicrobial drugs.
- “Drug delivery”: study and development of advanced “drug delivery” systems, such as lipid particles, vesicles and other nanoparticles, to improve the efficacy and safety of vaccines and antimicrobial drugs.
- Strategies to fight the emergence and spread of antibiotic-resistant bacteria at epidemic-pandemic risk
- Biomarkers of the immune response: discovery and validation of biomarkers of the immune response associated with infections at epidemic-pandemic risk, to improve the diagnosis and prognosis of infected patients and identify related protection.
